Episode 11: Could a Drug Cure Celiac Disease? (50 min.)

$0.00

<< Return to Courses

In this episode, Dr. Jocelyn Silvester describes how potential drug candidates for celiac disease could work as an adjunct to the gluten-free diet. Furthermore, Dr. Silvester explains how patients with celiac disease can be connected to clinical trials. Dr. Silvester also describes how to discuss eating gluten as part of clinical trials effectively with patients with celiac disease.

Category:

Description

Vanessa Weisbrod headshotVanessa Weisbrod
Director, Celiac Disease Program

 

 

 

 

Janis Arnold headshot

Janis Arnold, MSW, LICSW

Clinical Social Worker, Division of Gastroenterology, Hepatology, and Nutrition

 

 

 

Jocelyn Silvester headshotJocelyn Silvester, MD, PhD

Research Director, Celiac Disease Program; Attending Physician, Division of Gastroenterology, Hepatology, and Nutrition

Assistant Professor of Medicine and Pediatrics, Harvard Medical School

 

In this episode, Dr. Jocelyn Silvester describes how potential drug candidates for celiac disease could work as an adjunct to the gluten-free diet. Furthermore, Dr. Silvester explains how patients with celiac disease can be connected to clinical trials. Dr. Silvester also describes how to discuss eating gluten as part of clinical trials effectively with patients with celiac disease.


Learning Objectives: 

At the conclusion of this educational program, learners will be able to:

  1. Describe how potential drug candidates for celiac disease could work as an adjunct therapy to the gluten-free diet.
  2. Explain how patients with celiac disease can be connected to clinical trials.
  3. Understand how to discuss eating gluten as part of clinical trials effectively with patients with celiac disease.

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Social Worker

As a Jointly Accredited Organization, Boston Children’s Hospital is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Boston Children’s Hospital maintains responsibility for this course. Social workers completing this course receive 1.0 ACE CE continuing education credits.

Nurse

Boston Children’s Hospital designates this activity for 1.0 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. 

Dietician

Boston Children’s Hospital designates this activity for 1.0 contact hours for dieticians. Dieticians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: 

Vanessa Weisbrod: None

Janis Arnold, MSW, LICSW: None

Jocelyn Sylvester, MD, PhD: Consultant, Site PI on Clinical Trial, Takeda Pharmaceuticals; Consulting, GLG Group; Consulting, Alimentiv

Prachi A.: None

Additional information

Credit Type

, , ,

Duration

Format

Topic

Expiration Date

Release Date